Interstitial lung disease in rheumatoid arthritis
DP Ascherman - Current Rheumatology Reports, 2010 - Springer
Rheumatoid arthritis (RA) is the most common systemic autoimmune disease in the United
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
[引用][C] Interstitial Lung Disease in Rheumatoid Arthritis
DP Ascherman - Current Rheumatology Reports, 2010 - cir.nii.ac.jp
Interstitial lung disease in rheumatoid arthritis
DP Ascherman - Current rheumatology reports, 2010 - pubmed.ncbi.nlm.nih.gov
Rheumatoid arthritis (RA) is the most common systemic autoimmune disease in the United
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
Interstitial Lung Disease in Rheumatoid Arthritis
DP Ascherman - Current Rheumatology Reports, 2010 - infona.pl
Rheumatoid arthritis (RA) is the most common systemic autoimmune disease in the United
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
Interstitial lung disease in rheumatoid arthritis.
DP Ascherman - Current Rheumatology Reports, 2010 - europepmc.org
Rheumatoid arthritis (RA) is the most common systemic autoimmune disease in the United
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
States, affecting 1% to 2% of the adult population. Although joints and synovium are the …
Interstitial lung disease in rheumatoid arthritis
DP Ascherman - Current rheumatology reports, 2010 - scholarship.miami.edu
Abstract Lung Diseases, Interstitial-etiology Smoking-adverse effects Lung Diseases,
Interstitial-pathology Humans Immunosuppressive Agents-therapeutic use Citrulline …
Interstitial-pathology Humans Immunosuppressive Agents-therapeutic use Citrulline …